Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2026-02-13 @ 6:48 AM
Study NCT ID:
NCT02549651
Status:
COMPLETED
Last Update Posted:
2019-02-27
First Post:
2015-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-27
First Submit QC Date:
None
Study First Post Date:
2015-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-26
Last Update Post Date:
2019-02-27
Last Update Post Date Type:
ACTUAL